Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
NCT06133244 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-05-28
Summary
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Imaging, blood samples, fuctional tests and physical examination
Imaging, blood samples, fuctional tests and physical examination
Sponsors & Collaborators
-
University Medical Center Groningen
collaborator OTHER -
Radboud University Medical Center
collaborator OTHER -
Leiden University Medical Center
collaborator OTHER -
Royal Free Hospital NHS Foundation Trust
collaborator OTHER -
UMC Utrecht
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-19
- Primary Completion
- 2028-04-30
- Completion
- 2028-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
NCT01813279 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma
NCT04178616 ·Status: TERMINATED ·Phase: NA
-
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
NCT02558543 ·Status: TERMINATED ·Phase: PHASE2
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 ·Status: COMPLETED ·Phase: NA
-
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
NCT03059979 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis
NCT04481984 ·Status: COMPLETED ·Phase: NA
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
NCT03419208 ·Status: COMPLETED ·Phase: NA
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc
NCT02795221 ·Status: UNKNOWN
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
NCT02212249 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
NCT06291142 ·Status: COMPLETED
-
Bosentan in Systemic Sclerosis
NCT01395732 ·Status: COMPLETED ·Phase: PHASE4
-
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
NCT02206672 ·Status: UNKNOWN ·Phase: NA
-
BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA
NCT03629002 ·Status: UNKNOWN
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
NCT02480335 ·Status: COMPLETED ·Phase: PHASE4
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA